UK markets close in 1 hour 12 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,340.00-8.00 (-0.10%)
As of 3:03PM BST. Market open.
Full screen
Previous close8,348.00
Open8,390.00
Bid8,338.00 x 0
Ask8,341.00 x 0
Day's range8,337.00 - 8,409.00
52-week range6,499.80 - 10,120.00
Volume577,439
Avg. volume2,684,887
Market cap109.485B
Beta (5Y monthly)0.21
PE ratio (TTM)38.84
EPS (TTM)214.70
Earnings date29 Jul 2021
Forward dividend & yield2.07 (2.48%)
Ex-dividend date25 Feb 2021
1y target est78.83
  • Editor's pick
    Yahoo Finance Video

    Ethics have been ‘pushed to the back’ amid COVID-19: Doctor

    The Institute for Antiracism in Medicine Co-Founder & The University of Illinois College of Medicine Assistant Professor of Clinical & Family Medicine Dr. Brittani James joins Yahoo Finance Live to discuss the latest updates amid the COVID-19 pandemic.

  • AstraZeneca Covid-19 treatment fails to help those exposed to virus
    The Telegraph

    AstraZeneca Covid-19 treatment fails to help those exposed to virus

    An experimental antibody treatment designed to stop people developing Covid-19 after being exposed to the virus has failed clinical trials, dealing a blow to Britain's hopes of developing a new weapon to fight coronavirus. Anglo-Swedish drugmaker AstraZeneca gave an antibody drug to unvaccinated adults who had been exposed to Covid-19 within the past eight days. Antibody treatments are meant to work by pumping patients with antibodies to boost their immune system and stop them from developing a

  • AstraZeneca's 'Storm Chaser' COVID trial misses goal but offers some hope
    Yahoo Finance UK

    AstraZeneca's 'Storm Chaser' COVID trial misses goal but offers some hope

    AZD7442 failed to meet the main goal of stopping people developing symptomatic COVID-19 but did offer some hope that it could help people who had not yet come into contact with the virus.